Biosimilars Initiatives

Written by: CDHF

Updated: May 16th, 2023

CDHF is Canada’s trusted source for timely information on biosimilars initiatives across Canada. Click on your province to find out more information.

Biosimilars Initiatives by Region

Learn More About Biosimilars

Would you like to understand more about biosimilars including what they are, and the safety and efficacy of biosimilars? Visit our biosimilar library.

Resources

• Biosimilars Working Group
• Crohn’s and Colitis Canada
• Biosim Exchange
• CADTH Biosimilar Drugs | Fact Sheet
• Health Canada, Biosimilar Biologic Drugs in Canada | Fact Sheet
• Government of Canada | Guidance Documents: Information and Submission Requirements for Biosimilar Biologic Drug

---

Biologics & Biosimilars

Newfoundland and Labrador Biosimilars Policy

Biologics & Biosimilars Policy

Ontario Biosimilars Policy

Biologics & Biosimilars IBD

Switching from a Biologic to a Biosimilar Drug in Canada

Biologics & Biosimilars Policy

Saskatchewan Biosimilars Initiative

Biologics & Biosimilars Policy

Biosimilars Initiatives

Biologics & Biosimilars Policy

BC Biosimilars Initiative: Phase Two Information

Biologics & Biosimilars Policy

Alberta Health Biosimilars Initiative

Biologics & Biosimilars Policy

Nova Scotia Biosimilar Initiative

Biologics & Biosimilars CDHF Talks IBD

CDHF Talks: Dietary Updates and Recommendations for the IBD Patient on a Biosimilar

Biologics & Biosimilars Policy

Quebec Biosimilars Initiative

Biologics & Biosimilars Policy

New Brunswick Biosimilars Initiative

Biologics & Biosimilars IBD

Switching from a Biologic to a Biosimilar

Biologics & Biosimilars

What’s Health Canada Saying about Biosimilars?

Biologics & Biosimilars IBD

Biosimilars for IBD: Making the Transition Webinar

Biologics & Biosimilars CDHF Talks IBD

CDHF Talks: Your New Infusion Clinic